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Shared decision making (SDM) in mental health care involves clinicians and patients
working together to make decisions. The key elements of SDM have been identified,
decision support tools have been developed, and SDM has been recommended in
mental health at policy level. Yet implementation remains limited. Two justifications are
typically advanced in support of SDM. The clinical justification is that SDM leads to
improved outcome, yet the available empirical evidence base is inconclusive. The ethical
justification is that SDM is a right, but clinicians need to balance the biomedical ethical
principles of autonomy and justice with beneficence and non-maleficence. It is argued
that SDM is “polyvalent”, a sociological concept which describes an idea commanding
superficial but not deep agreement between disparate stakeholders. Implementing SDM
in routine mental health services is as much a cultural as a technical problem. Three
challenges are identified: creating widespread access to high-quality decision support
tools; integrating SDM with other recovery-supporting interventions; and responding to
cultural changes as patients develop the normal expectations of citizenship. Two
approaches which may inform responses in the mental health system to these cultural
changes – social marketing and the hospitality industry – are identified.
Key words: Shared decision making, mental health care, ethics, implementation, routine
outcome monitoring, social marketing
Decision making is a complex and dynamic social interaction1. The balance of
involvement between clinician and patient can be conceptualized as lying on a
continuum from clinician-led/passive/paternalistic, through shared, to patient-
led/informed/active2. Clinician-led decision making occurs when the clinician makes the
decision for the patient, possibly after consulting with him/her. Patient-led decision
making occurs when the patient makes the decision, possibly having received
information from the clinician. The intermediate position of shared decision making
(SDM) involves collaboration.
A widely used definition of SDM is that it is “a process in which clinicians and
patients work together to select tests, treatments, management or support packages,
based on clinical evidence and the patient’s informed preferences; it involves the
provision of evidence-based information about options, outcomes and uncertainties,
together with decision support counselling and a system for recording and implementing
patients’ informed preferences”3. This definition focuses, as does the present paper, on
interactions between clinicians and patients, but SDM also has relevance to decision
making between clinicians and family members, and perhaps also to clinical discussion
between different professional groups.
What is a decision? In physical health care, decisions might include whether to
complete a diagnostic test, undergo a medical procedure, receive a particular
pharmacological or psychological treatment, or attempt a lifestyle change. In mental
health, decisions relating to inpatient care are broadly similar. When asked to name
recent clinical decisions, inpatients with a diagnosis of schizophrenia (N=60) and their
psychiatrists (N=30) consistently mentioned categories such as “medication”, “leave from
ward/hospital”, “non-pharmacological therapies” and “changes in treatment setting”4. By
contrast, decision making in community mental health settings is more wide-ranging; a
principal component analysis of topics discussed in routine consultations between
community patients (N=418) and their clinicians found a three-factor solution comprising
treatment, social (family, friends, leisure) and financial (work, benefits)5.
The essential elements of SDM have been identified. A systematic review
synthesized 161 conceptual models of SDM to identify eight characteristics of clinician
behaviour: define/explain the health care problem, present options, discuss
benefits/risks/costs, clarify patient values/preferences, discuss patient ability/self-
efficacy, present what is known and make recommendations, clarify the patient’s
understanding, and make or explicitly defer a decision6. This framework underpinned a
systematic review of implementation of SDM across different health care settings,
identifying five randomized controlled trials of interventions to improve clinicians’
adoption of SDM7. Training of clinicians and use of decision aids (structured approaches
to facilitate SDM) were tentatively recommended, though none of the studies related to
mental health populations.
Patients want SDM8. A systematic review of 199 analyses from 115 studies of
decision-making style preference concluded that patients prefer shared to clinician-led
decision making, with the preference proportion higher in studies carried out in patients
with cancer or undergoing invasive procedures, compared to those conducted in non-
disease specific study populations or patients with other chronic conditions9.
Overall, there is international consensus across medicine about the importance of
SDM10, and it is widely supported11. It is argued that SDM leads to better outcomes,
including help-seeking behaviour12, increased compliance with decisions13, reduction in
errors14, reduced stigma and increased involvement15. In 2010, a gathering of 58 experts
from 18 countries produced the Salzburg Statement on Shared Decision Making16. This
included a call for clinicians to recognize SDM as an ethical imperative, stimulate two-
way flow of accurate and tailored information, and give patients and their families
resources and help to reach decisions. The statement also exhorted action by
researchers, editors, journalists, patients (to speak up, to expect to be an equal partner,
to seek and use high-quality information) and policy makers.
SHARED DECISION MAKING IS RECOMMENDED IN MENTAL HEALTH
SDM is promoted in mental health systems17. It is advocated as an important
approach in the mental health policy of many countries internationally10. For example, in
England it is recommended that “a shared decision making approach should be
facilitated” across all adult mental health services18.
Why is SDM in mental health so widely recommended? The standard argument
made to support SDM is that clinicians have expertise in diagnosis, etiology, prognosis,
treatment options and outcome probabilities, whereas patients have expertise in illness
experience, social circumstances, attitudes to risk, values and preferences3. Bringing
these two types of expertise together can, when informed by research evidence,
produce better decisions. However, this standard argument conflates two overlapping
but separate justifications: clinical and ethical.
The clinical justification
The clinical justification put forward for SDM is that patients who are active
participants in managing their care have better outcomes. Increased involvement will
lead to better engagement, higher-quality decision making, and increased treatment
adherence – all of which will improve outcome. There is some evidence supporting this
justification. For example, a trial in the Netherlands involving 220 psychiatric inpatients
showed that SDM led to reduced substance use and improved quality of life19. A follow-
up study found that SDM was also associated with increases in patient autonomy20.
However, critical appraisal of all available evidence is less positive. A Cochrane
review of SDM in mental health21 identified only two randomized controlled trials. Both
studies took place in Germany, one involving 107 patients with a schizophrenia
diagnosis22 and the other 405 patients with depression23. The Cochrane review
concluded that there was no evidence for harm, but the weak evidence base meant that
no firm conclusions could be drawn. Since that review, one randomized controlled trial
involving 80 community patients24, also showing advantages for decision aids, has been
published.
Other reviews have reached similar conclusions. A systematic review25 identified
eleven randomized controlled trials, including two in mental health, one focussing on
schizophrenia26 and the other on depression27. Five trials, including the two mental
health trials, showed positive outcomes associated with SDM, but the reviewers
concluded that the overall evidence is encouraging but inconclusive.
It should be noted that this conclusion is not unique to mental health. The most
recent systematic review of trials (N=22) testing the impact of SDM on outcome in
physical health concluded: “The trials performed to date to address the effect of SDM on
patient-relevant, disease-related endpoints are insufficient in both quantity and quality.
Although just under half of the trials reviewed here indicated a positive effect, no final
conclusion can be drawn”28. But available evidence does suggest that SDM in mental
health is particularly challenging. For example, SDM leads to a greater increase in
treatment adherence in general medicine than in mental health29.
Overall, the totality of evidence is inconclusive about the impact of SDM on patient
outcomes in mental health.
The ethical justification
The ethical justification put forward for SDM is that it is a human right. Sometimes
expressed as “No decision about me without me”3, the right to self-determination implies
full involvement in decisions affecting the person. This seems to be a view increasingly
taken by patients: the above-mentioned 2012 systematic review of 115 studies
investigating decision-making preferences9 identified a patient preference for SDM in
63% of studies, but a time trend was evident, with 50% of studies before 2000 and 71%
after 2000 showing this preference.
Reviews of SDM in persons with schizophrenia30 and depression31 showed that
patients and clinicians found SDM acceptable and did in fact engage in SDM, which
resulted in improvements in patients’ knowledge about their illness and a higher level of
perceived involvement in decision making.
The ethical justification is often positioned as a solution to the suggested problem of
an assumption that the clinician is the only competent decision maker, who will make
decisions for rather than with the patient. Ethical justifications emphasize that “clinicians
and patients bring different but equally important forms of expertise to the decision-
making process”3. Arguments made from this perspective often focus on values and
power relationships, for example by linking SDM with values-based practice32. SDM is
understood primarily as a process involving the expert-by-training (the clinician) and the
expert-by-experience (the patient) both contributing their expertise, committing to
decision-making responsibility, and being respectful of the other’s perspective. This
transactional focus contrasts with the clinical justification emphasis on producing better
outcomes.
Shared decision making is a polyvalent concept
SDM is thus supported both by those who prioritize clinical expertise and expertise-
by-experience. In this sense, the term is what sociologists call a polyvalent concept33 –
one which commands superficial agreement and apparent consensus between disparate
stakeholders, but which conceals incompatible assumptions and expectations. Put
concretely, does the clinician still support SDM if it leads to empowered patients who are
less adherent to treatment recommendations? Does the patient still support SDM if
apparently involving conversations that seem somehow always to end up with the
clinician’s view prevailing34?
There are particular challenges in mental health care35. Is SDM still the best
approach to decision making with non-capacitous adults, such as those with advanced
dementia or acute psychosis36? Is it appropriate in a forensic context, where the
decisions that the person makes may fall slightly or greatly outside social norms?
These tensions between different justifications for shared decision making also
occur in other initiatives in mental health. The same features of apparent universal
agreement occur in relation to the service agenda and rights agenda which both provide
support for anti-stigma initiatives37. Other polyvalent constructs include self-
management, advance directives and social inclusion.
For example, recovery has emerged as a guiding vision for mental health systems38.
Like the ethical justification for SDM, a recovery orientation involves a re-focussing on
subjectively-defined process rather than clinician-defined outcome. The relevance of
recovery to dementia39, forensic40 and mental health inpatient services41, however, has
been questioned. A focus on recovery creates challenges for clinicians and patients.
Clinicians have the uncomfortable experience of competing priorities42 leading to role
tensions43, yet advocates raise concerns that recovery is being “commandeered”44 to
individualize social problems, to de-politicize individual experience and to remain
focussed on deficit amelioration45. The recommendation that sociological research is
needed to understand the socio-cultural meaning and implications of recovery46 is
probably equally applicable to SDM.
HOW IS SHARED DECISION MAKING IMPLEMENTED IN MENTAL HEALTH?
SDM is not yet widely implemented across mental health systems. For example, in
the National Health Service (NHS) Community Mental Health Survey 2015 in England47,
only 42% – a reduction on 201448 – fully agreed with the statement “Have you agreed
with someone from NHS mental health services what care you will receive?” (N=12,695).
Only 50% fully agreed with the statement “Were you involved as much as you wanted to
be in decisions about which medicines you receive?” (N=9,775), and among patients
who received non-pharmacological treatments, only 55% fully agreed with “Were you
involved as much as you wanted to be in deciding what treatments or therapies to use?”.
Is there a difference between SDM in mental versus physical health? A study in the
Canary Islands compared experience of decision making between patients attending
psychiatric outpatient clinics and primary care (N=1,477)49. It found no difference in
overall score, but differences at the item level. Participants using psychiatric outpatient
services said that they were helped to understand the information, but were more likely
to say that they were not asked about which treatment option they preferred, that there
was no negotiation, and that the selection of treatment was not a consensus decision.
There may be challenges specific to SDM in mental health.
A qualitative investigation of the views of experienced psychiatrists (N=26) identified
barriers to its use in relation to prescribing50. The most frequently identified barrier was
beliefs about the insight of the patient, which in some cases was seen as an absolute
barrier. Other challenges were societal expectations about mental disorder (so statutory
powers are held by the psychiatrist), beliefs about the primacy and the tranquillizing
effects of antipsychotic medication, and financial pressures limiting options.
These barriers may lead to SDM conversations in mental health being more factual
than values-based. An exploration using factor analysis of decision making in psychiatric
visits in the U.S. (N=191) found that discussions about the science (pros and cons,
clinical issues and uncertainties, consumers’ goals and understanding) were more
common than about preferences (the consumer’s role in decision making, discussion of
alternatives, exploration of preferences)51.
Other implementation challenges have been identified in physical health10 and
mental health52 settings, such as hierarchical doctor-patient relationships53, differing
understandings of, and low commitment to, SDM54, lack of a “rights discourse” in the
culture55, and challenges of avoiding inequities when access to support tools is through
insurance-funded health systems56.
RESEARCH IN ROUTINE CLINICAL SETTINGS
Given these implementation challenges, research in routine mental health services
is needed. The European Union-funded “Clinical decision making and outcome in routine
care for people with severe mental illness” (CEDAR) study took place in six European
countries (Denmark, Germany, Hungary, Italy, Switzerland and UK) from 2009 until
201457. The study had two aims.
The first aim was to establish a methodology to assess clinical decision making in
people with severe mental illness. This aim was met by the development and cross-
cultural validation of three new measures. All of them comprised parallel clinician and
patient versions, and were developed in English followed by rigorous translation and
cultural adaptation using good practice guidelines58 into Danish, German, Hungarian and
Italian. The Clinical Decision Making in Routine Care (CDRC) measure assesses the
content and implementation of decisions59. The Clinical Decision Making Style (CDMS)
measure assesses preference for different styles of decision making60. The Clinical
Decision-making Involvement and Satisfaction (CDIS) measure assesses involvement
and satisfaction in a specific decision. All measures are available at www.cedar-
net.eu/instruments.html.
The second aim was to investigate decision making in routine adult community-
based mental health services, using a six-country prospective observational design. A
total of 588 patients met inclusion criteria, primarily comprising age 18-60 with mental
disorder present (established using research diagnosis61), severe62 and enduring for two
years. After giving consent, patients identified a clinician, and these clinician-patient
dyads were then asked to complete bimonthly assessments for one year.
The main study investigated the relationship between decision making style and
outcome63. A preference for shared, rather than patient-led or clinician-led, decision
making was reported by both patients (χ2=135.08, p<0.001) and clinicians (χ2=368.17,
p<0.001). SDM was also the dominant experience, with a 10% increase in the proportion
of both groups reporting SDM over the one-year study period. Hierarchical linear
modelling found that the decision-making style of clinicians significantly affected patient-
rated unmet needs over time, with unmet needs decreasing more in patients whose
clinicians preferred patient-led to clinician-led (−0.406 unmet needs per two months, 
p=0.007) or shared (−0.303 unmet needs per two months, p=0.015) decision making. In
other words, outcomes were best when clinicians supported patient-led decision making.
A second study investigated the relationship between decision-making involvement
and satisfaction64. Patients (N=445) were partitioned based on involvement preferences
(assessed using CDMS) and experiences (assessed using CDIS). The preference
hypothesis was that satisfaction with a specific decision will be higher if it is made using
the patient’s preferred decision-making style (patient-led, shared, clinician-led). This was
not confirmed. Overall, 90 patients (20%) had less involvement than preferred
(“disempowered”), 190 (43%) were “matched” and 162 (37%) were “empowered”.
Empowered patients, who experienced more involvement in decision making than they
desired, rated highest satisfaction (OR=2.47, p=0.005, 95% CI: 1.32-4.63). The
agreement hypothesis was that satisfaction will be higher when decisions are made with
a clinician with the same preferred decision-making style. This was also not confirmed,
with ordinal logistic regression modelling showed that decisions made with clinicians
whose decision-making style preference was for more active involvement than the
patient preference were rated with highest satisfaction (OR=3.17, p=0.003, 95% CI:
1.48-6.82). So, higher satisfaction was experienced following more active involvement in
decision making than the patient stated as desired, and with a clinical orientation
towards empowering, rather than shared, decision making. This is consistent with
findings from other health sectors. For example, a primary care study (N=1,913) in
Germany found that high experienced involvement predicted higher patient
satisfaction65.
The CEDAR study has two implications for routine practice. First, if the intention is
to reduce patient-rated unmet needs and to maximize satisfaction, then the empirical
findings indicate that long-term efforts should be oriented towards developing patient-led
rather than shared decision making. This is challenging to the current culture of health
services. Patient-led decision making is not always valued by the system; a patient
preference for involvement has been found to be negatively associated with experienced
involvement65. Socio-political debate would be needed about the purpose of the mental
health system – to what extent is the “core business” of the system keeping people
(patients and others) safe, which may necessarily involve some clinician-led decision
making, versus supporting them to live as well as possible? Can and should we socialize
clinicians into a professional role which gives primacy to patient-led decision making?
Clinical practice would need to be oriented towards supporting this type of patient
empowerment, with a recovery-oriented culture in mental health systems which
promotes the normal entitlements of citizenship66. We know that the desire to participate
in decision making is higher in some groups of patients, e.g. inpatients with experiences
of involuntary treatment, with negative attitudes toward medication, with a higher level of
education, with lower treatment satisfaction, with better perceived decision-making skills,
in patients of female gender and in younger patients30. Should efforts to support patient-
led decision making be targeted at these patient subgroups, or at all patients?
Also, patients may bring expectations about being looked after whilst unwell. When
is this expectation helpful, and when is it ultimately harmful? Recovery is far more
common than often understood in mental health systems67,68, and access to peer
workers can powerfully transform these role expectations69. How do we minimize harm,
balancing the reality that being allowed to disengage from services leads to the best
outcome for some people70 and to avoidable tragedies for others?
The second implication is that an orientation towards SDM is an empirically
defensible goal in mental health systems which have traditionally used clinician-led
decision making. An SDM orientation will improve both patient experiences and
outcomes, indicating an alignment between the clinical and ethical justifications for SDM
as a more beneficial style than clinician-led decision making. If it is accepted that SDM is
a necessary component of a modern mental health system, then three challenges can
be identified: the technical problems of access to appropriate tools and integration with
other innovations, and addressing the implications of changing culture.
DECISION SUPPORT TOOLS
Changing practice often involves the use of formal decision support tools, and
resources exist to support SDM. For example, online decisions support systems are
available which are both generic (e.g., optiongrid.org) and condition-specific (e.g.,
sdm.rightcare.nhs.uk/pda and thedecisionaidcollection.nl for depression).
These tools may target behaviour change in either clinicians or patients. Clinician-
focussed approaches typically involve training and support for practice change. These
approaches have been evaluated in depression, and (when augmented with patient
information leaflets giving information and encouragement towards involvement) they
lead to improved patient participation and satisfaction without adding to consultation
time23.
A good example of a patient-focussed approach is the CommonGround system,
which is an online peer-delivered decision support system to support patient involvement
and empowerment in psychopharmacology consultations71.
Widespread access to generic and condition-specific decision support tools is
needed. Tools need to be of a high quality: a systematic review of decision aids across
medicine found a tendency to under-specify the procedure, to emphasize benefits more
than harms, and to focus more on false positives than on false negatives in screening
tools72. Development of reporting guidelines for decision aid studies would be one
approach to improving quality73.
Decision support tools also need to be small in number: the same systematic review
identified 68 tools relating to treatment and 30 relating to screening. This variation
makes benchmarking and comparison between services and systems more difficult28.
Finally, there needs to be a focus on tailoring and testing tools in different clinical groups
and geographical locations. The extent to which patients expect to be actively involved in
treatment decisions varies according to the prevailing culture74. In paternalistic cultures,
both clinicians and patients are likely to assume that decisions are the responsibility of
the clinician only, whereas in more egalitarian cultures a partnership or SDM approach
may be jointly preferred75. Translation processes therefore need to address these
cultural factors in ensuring both linguistic and conceptual equivalence58.
INTEGRATION WITH OTHER RECOVERY-SUPPORTING INNOVATIONS
Implementation of SDM will involve the integration of the relevant technologies with
wider innovations, and the application of improvement science to support evaluation and
sustainable implementation. A number of measures of SDM now exist: a structured
review identified 19 measures, and a move towards measuring processes from both
patient and clinician perspectives76. These provide standardized approaches to evaluate
complex interventions which integrate SDM with other established innovations.
Advanced directives and joint crisis plans are examples of established innovations77.
Advance directives involve the patients pre-specifying their preferences for what should
occur if they lose capacity due to mental illness. An emergent problem with this patient-
led approach was that the clinician might not be involved in, or even aware of, the
directive in advance, leading to low implementation78. A variant involving SDM has
emerged, called joint crisis plans. These are developed through facilitated meetings
between the patient and involved clinicians79. A randomized controlled trial involving 569
patients in 64 community mental health teams in England found that implementation by
clinicians was the main challenge, with no significant treatment effect for the primary
outcome of compulsory admissions, or any secondary outcome with the exception of
improved therapeutic relationships80. Qualitative investigation identified four barriers to
clinician engagement: ambivalence about care planning; perceptions that they were
“already doing SDM”; concerns regarding the clinical “appropriateness of service users’
choices”; and limited “availability of service users’ choices”81.
Another example of integration is with the emergent field of routine outcome
monitoring82, which involves the longitudinal collection of patient-level outcome
information to inform individualized care. There is strong evidence of short-term benefit
and moderate evidence of longer-term benefit from routine outcome monitoring83. A
study is now underway which integrates SDM and that monitoring84. Routinely collected
outcome data are fed into the SDM process, with the intervention supported by a quality
improvement collaborative programme involving a national and local implementation
strategy.
ETHICAL AND CULTURAL CHALLENGES OF IMPLEMENTATION
Although most clinicians believe that they are using the SDM approach, there is
evidence to the contrary85. Perceptions about level of involvement differ, with patients
identifying more clinician-led and clinicians identifying more shared approaches86.
Patients report inhibiting factors including the patient-clinician relationship, fear of being
judged, perceived inadequacy, and a history of substance abuse87. The use of clinician-
led decision making is most pronounced in treatment-related decisions5.
One reason for low implementation is represented by ethical tensions. A widely-
used biomedical ethical framework identifies four principles: respect for autonomy,
justice, beneficence and non-maleficence88. Skilled clinicians attempt to integrate these
principles, for example supporting patient participation not just for reasons of autonomy
but also justified by beneficence (as well as other influences, such as avoiding legal
liability)89. However, engagement remains challenging90. The potential conflict between
these principles has been characterized in relation to antipsychotic prescribing for a
patient who lacks insight; the psychiatrist may think: “If I leave it up to the patient, he
would certainly choose not to initiate treatment. Symptoms would persist or even
worsen, and thus I would harm the patient. If I apply pressure and he accepts
antipsychotics, he may respond to treatment and likely gain insight. Then he will later be
thankful that I proceeded in the way I did”91. This reflects the tension between
deontological (duty-based) ethical frameworks emphasized in the training of many
professional groups and teleological (rights-based) frameworks emphasized by citizens.
A second reason for low implementation is cultural. An asylum-based system
creates a micro-culture (a “total institution”92) which can be out of step with wider cultural
values. Institutional structures can powerfully socialize a patient into a moral duty to be
treatment-adherent (a “good” patient) and respectful of the clinician’s sapiential expertise
and professional authority. When the dominant discourse is clinician-led, a primary flow
of information from clinician to patient means that the patient’s values and treatment
preferences are given less importance93. Overall, it is difficult to avoid clinician-led
decision making being the default choice in institution-based mental health services,
because SDM involves a shift in power arrangements94.
TRANSFORMATION IN THE MENTAL HEALTH SYSTEMS
The world is changing. Mental health systems internationally are transitioning
towards community-based services95-101, which involve interactions with patients who are
more influenced by citizenship expectations relating to consumerism, self-determination
and empowerment102. Patients increasingly expect as a right to be active participants in
decisions about their lives, with a greater emphasis on the biomedical ethical principles
of autonomy and justice.
The implications of this shift for mental health systems are profound, and extend
well beyond discussion of approaches to decision making. Disruptive organizational
transformation may be needed if the mental health systems are to survive this transition
to engaging with patients holding citizenship expectations. A readiness to draw in
insights and use language and constructs from other sectors will be needed to inform
this transformation. This can be illustrated by two examples, both of which are potentially
relevant but currently almost unused in planning and developing mental health systems.
The first example is given by the academic discipline of social marketing103, which
could be used as an approach to fostering culture change in mental health systems.
Social marketing involves the application of marketing principles and practices to
advance social good, in this case participation in decision making. It takes a citizen-
centred approach in which insights developed with citizens and stakeholders inform the
process104. An orientation towards mutuality, exchange and reciprocity differentiates
social marketing from other social intervention approaches, particularly in traditional
expert-driven, top-down public health approaches. So, social marketing provides an
approach to developing citizen-centred mental health systems oriented around the
preferences of participants (patients), and in which partnership working (shown for
example by SDM) is the foundation rather than a feature to be added on.
Participatory approaches to service development already exist in mental health
services. Peer support theories such as intentional mutuality emphasize relationships in
which both people have value and reciprocity is possible105. Recovery Colleges are
based on principles of collaboration, co-production, inclusiveness and a community
focus106. Similarly, “a majority of participants in user-run programmes value role equity,
the mutuality and reciprocity of relationships and the non-hierarchical organization”107.
Market segmentation is a well-established business technique used to identify and
manage diverse customer needs and to target marketing resources108. Positioning
similar groups of people into market segments, and then focusing marketing efforts at
these different segments as appropriate can manage heterogeneity in preferences. By
developing marketing strategies and behaviour change strategies for distinct groups of
patients who have specific needs or values, it becomes possible to influence culture and
create demand for SDM in clinicians working with, and patients coming from, different
clinical populations.
The second example is given by the expertise held by the hospitality industry in
working with disparate customers: “Key values, such as the importance of welcome, the
customer always being right and the job being to provide help to meet the customer’s
needs, underpin the best interactions in this service industry. Hospitality workers are
skilled in recognising how customers like to be engaged with – from face-to-face to
elbow-to-elbow. Workers are not doing their job if customer care is poor”109. If patients
achieve similar levels of emancipation and agency as other citizens, then patient choices
and preferences become central. If clinicians don’t work in partnership with patients to
ensure they have a positive experience, then patients will – and should – choose to go
elsewhere for support.
CONCLUSION
In this paper, the case has been made that SDM is part of a broader movement of
change in the mental health system110. There are implementation challenges, but these
are ethical and cultural as well as technical.
It is worth addressing these complex issues relating to power, control, expertise and
valued knowledge, because SDM has the potential to contribute to supporting people to
live as well as possible in communities of their own choosing.
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